Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) |
| BNF code | 1404000ATBGAAAF |
| Virtual Medicinal Product | Generic Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials |
| Name | Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials |
| Abbreviated name | Comirnaty COVID-19 mRNA Vaccine 0.3ml inj multidose vials |
| Date of name applicability | 8 Sep 2021 |
| Previous name | COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials |
| Supplier | Pfizer Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| Previous licensing authority | None |
| Reason for change of licensing authority | Licence Granted |
| Date of change of licensing authority | 10 Dec 2020 |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) 1170 dose 195 x 6 dose vials | |
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) 6 dose | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.